Market Cap

AstraZeneca Market Capitalization:

AstraZeneca plc

£186.90 Billion

GBP as of July 1, 2024

US$236.45 Billion

business AstraZeneca Company Profile

AstraZeneca Main Stock Listing


Market capitalization history of AstraZeneca

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of AstraZeneca market cap

Date Market Cap YoY Change
Jan. 1, 2024 £166.77 B -7.76%
Jan. 1, 2023 £180.79 B 34.62%
Jan. 1, 2022 £134.30 B 15.03%
Jan. 1, 2021 £116.75 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +191.38%

$10,000 in June 2023 would now be $29,138 by following this algorithm daily at market close.

Boost your returns with Disfold DeepFinance... Now!

Try Disfold DeepFinance FREE

Company Description

AstraZeneca PLC is an Anglo–Swedish multinational pharmaceutical and biopharmaceutical company. AstraZeneca develops, manufactures, and sells pharmaceuticals and biotechnology products to treat major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

business AstraZeneca Company Profile

Stocks & Indices

AstraZeneca plc has the following listings and related stock indices.

Stock: LSE: AZN

Stock: BCBA: AZN

Stock: BMV: AZNN

Stock: FSX: ZEG

Stock: FSX: ZEGA

Stock: OMX: AZN



Stock: XETR: ZEG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.